Name: Alzheimer'S Disease Drug Development: Research and Development Ecosystem (en Inglés)
Price: 560.76 PEN
Availability: InStock
Author: Cummings, Jeffrey ; Kinney, Jefferson ; Fillit, Howard
ISBN: 9781108838665

portada Alzheimer'S Disease Drug Development: Research and Development Ecosystem (en Inglés)

Formato

Libro Físico

Ilustrado por

Jeffrey Cummings

Jefferson Kinney

Howard Fillit

Editorial

Cambridge University Press

Autor

Cummings, Jeffrey ; Kinney, Jefferson ; Fillit, Howard

Año

2022

Idioma

Inglés

N° páginas

387

Encuadernación

Tapa Dura

Dimensiones

25.4 x 17.8 x 3.2 cm

Peso

1.21 kg.

ISBN13

9781108838665

Categorías

Neurología y neurofisiología clínicas

Alzheimer'S Disease Drug Development: Research and Development Ecosystem (en Inglés)

Jeffrey Cummings (Ilustrado por) · Jefferson Kinney (Ilustrado por) · Howard Fillit (Ilustrado por) · Cambridge University Press · Tapa Dura

Libro Nuevo

S/ 560,76

S/ 1.121,52

Ahorras: S/ 560,76

50% descuento

Envío normal

Origen: Estados Unidos (Costos de importación incluídos en el precio)

Se enviará desde nuestra bodega entre el Lunes 17 de Junio y el Lunes 01 de Julio.

Lo recibirás en cualquier lugar de Perú entre 2 y 5 días hábiles luego del envío.

Reseña del libro "Alzheimer'S Disease Drug Development: Research and Development Ecosystem (en Inglés)"

Alzheimer's Disease (AD) is a growing global public health challenge. The development of new therapies is urgently needed, and a complex ecosystem of organizations has grown to facilitate AD drug discovery and development. Masterfully collating information on the drug development ecosystem, this book emphasizes the contributions of each aspect in the pipeline with a uniform approach to chapters, enabling readers to access relevant information quickly. Topics covered include the use of non-clinical laboratory studies, biomarker development, artificial intelligence, design and management of clinical trials, and funding and financing models. Also discussed is the critical role of advocacy fundraising for drug development. With the approval of aducanumab, the function of the ecosystem has become apparent. This is a definitive overview of how the ecosystem works in transferring an AD drug from its discovery in the laboratory through clinical trial testing to regulatory review and eventual marketing.